Scienture (NASDAQ:SCNX) Releases Earnings Results, Beats Expectations By $0.02 EPS

Scienture (NASDAQ:SCNX – Get Free Report) posted its earnings results on Thursday. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.02, FiscalAI reports. The firm had revenue of $0.34 million during the quarter, compared to analyst estimates of $1.96 million.

Scienture Stock Performance

NASDAQ SCNX traded up $0.01 on Thursday, hitting $0.47. 1,153,556 shares of the stock were exchanged, compared to its average volume of 1,939,076. The business’s fifty day moving average is $0.38 and its 200 day moving average is $0.40. Scienture has a 52 week low of $0.24 and a 52 week high of $2.60.

Get Scienture alerts:

Institutional Investors Weigh In On Scienture

An institutional investor recently raised its position in Scienture stock. Geode Capital Management LLC increased its stake in shares of Scienture Holdings, Inc. (NASDAQ:SCNX – Free Report) by 264.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 316,201 shares of the company’s stock after buying an additional 229,398 shares during the period. Geode Capital Management LLC owned 0.78% of Scienture worth $161,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 5.68% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Scienture in a report on Wednesday, June 24th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $1.50.

Check Out Our Latest Stock Report on Scienture

About Scienture

(Get Free Report)

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

Further Reading

• Five stocks we like better than Scienture
• Asian Market Circuit Breakers Hit Stocks, Not AI Demand
• Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
• Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
• Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal

Receive News & Ratings for Scienture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scienture and related companies with MarketBeat.com's FREE daily email newsletter.